Endocrine Issues at Day 1 of life

1. Introduction

Endocrine disorders on the first day of life are medical emergencies. Early recognition is critical to prevent metabolic collapse (hypoglycemia, shock), incorrect gender assignment, or long-term neurodevelopmental sequelae. Diagnosis primarily relies on recognizing clinical "red flags" before screening results are available.

2. Presentation A: Ambiguous Genitalia (DSD)

The most common endocrine cause for ambiguous genitalia is Congenital Adrenal Hyperplasia (CAH).

3. Presentation B: Refractory Hypoglycemia

Hypoglycemia on Day 1 that requires high Glucose Infusion Rates (GIR > 8-10 mg/kg/min) suggests an endocrine etiology.

4. Presentation C: Physical Stigmata & Dysmorphism

Certain syndromes with endocrine components present with visible signs on Day 1.

5. Presentation D: Electrolyte Abnormalities

6. Diagnostic Work-up: "The Critical Sample"

If a neonate presents with hypoglycemia or ambiguous genitalia, blood samples must be drawn during the acute event (before correcting glucose if possible, or immediately after).

A. Hypoglycemia Panel (Critical Sample):

B. Ambiguous Genitalia Panel:

C. Thyroid Profile: T3, T4, TSH (on cord blood or venous sample).

7. Management Principles

  1. Stabilize Glucose: IV Dextrose bolus (2ml/kg of 10%) followed by high GIR infusion.
  2. Rescue Steroids: If cortisol deficiency (Hypopituitarism/CAH) is suspected, give Hydrocortisone after drawing the sample.
  3. Correct Electrolytes: Calcium gluconate for hypocalcemic seizures.
  4. Counseling: Defer naming/gender assignment in ambiguous genitalia cases until karyotype is confirmed.